QA: BeiGene Ltd. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651308_2022_BeiGene_Ltd.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.0003724791556418626, 'aggregate_val': 2589784000, 'exp_sum': 2590749000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 164906000, 'SellingGeneralAndAdministrativeExpense': 990123000, 'ResearchAndDevelopmentExpense': 1459239000, 'remainder_Expenses': -23519000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001651308, BeiGene Ltd.

  xvar xval
0 AssetsCurrent 7,613,880,000
1 IntangibleAssetsNetIncludingGoodwill 46,679,000
2 PropertyPlantAndEquipmentNet 587,605,000
3 remainder_Assets 397,785,000
4 LiabilitiesCurrent 1,599,555,000
5 LiabilitiesNoncurrent 803,407,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 164,906,000
8 SellingGeneralAndAdministrativeExpense 990,123,000
9 ResearchAndDevelopmentExpense 1,459,239,000
10 remainder_Expenses -24,484,000
11 remainder_Revenues 1,176,283,000
12 remainder_NetIncome 147,000
13 remainder_ComprehensiveNetIncome 11,008,000
  yvar yval
0 Assets 8,645,949,000
1 Liabilities 2,402,962,000
2 Expenses 2,589,784,000
3 Revenues 1,176,283,000
4 StockholdersEquity 6,242,987,000
5 NetIncome -1,413,354,000
6 ComprehensiveNetIncome -1,407,850,000
7 BaseVar 7,413,066,500
8 EconomicCapitalRatio 1.69

Edgar->Model Mapping

Feature Distribution

Change over Time